Interestingly, in FIRE3 the overall survival increased from 28 months to 51 months between Siglec‐XII expressers and non‐expressers (Figure 3E,F), that is, a correlation between Siglec‐XII expression and poor prognosis in late‐stage colorectal cancer. Here, SIGLEC12 is linked to colorectal cancer.